€2m boost for gene and cell therapy info hub
15 April 2021
A new EU-funded project is set to provide accessible and reliable information about cell and gene-based therapies. The € 2m initiative will develop an online hub to provide accurate information on the use of cells and genetic material to treat disease, along with evidence-based information to counter misinformation...
Researchers call for greater awareness of unintended consequences of CRISPR gene editing
15 April 2021
CRISPR-Cas9 genome editing can lead to unintended mutations at the targeted section of DNA in early human embryos, researchers have revealed. This highlights the need for further research into the effects of CRISPR-Cas9 genome editing, especially when used to edit human DNA in laboratory research. We and others are trying...
Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital
26 March 2021
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19. Having survived the trauma of being hospitalised with COVID-19, far too many patients find themselves back in hospital with new or long term complications Charlotte Summers The clinical trial...
© 2021 University of Cambridge
